These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

724 related articles for article (PubMed ID: 26556856)

  • 1. Leptin as a mediator of tumor-stromal interactions promotes breast cancer stem cell activity.
    Giordano C; Chemi F; Panza S; Barone I; Bonofiglio D; Lanzino M; Cordella A; Campana A; Hashim A; Rizza P; Leggio A; Győrffy B; Simões BM; Clarke RB; Weisz A; Catalano S; Andò S
    Oncotarget; 2016 Jan; 7(2):1262-75. PubMed ID: 26556856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activated FXR Inhibits Leptin Signaling and Counteracts Tumor-promoting Activities of Cancer-Associated Fibroblasts in Breast Malignancy.
    Giordano C; Barone I; Vircillo V; Panza S; Malivindi R; Gelsomino L; Pellegrino M; Rago V; Mauro L; Lanzino M; Panno ML; Bonofiglio D; Catalano S; Andò S
    Sci Rep; 2016 Feb; 6():21782. PubMed ID: 26899873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of fibroblasts on breast cancer cell mammosphere formation and regulation of stem cell-related gene expression.
    Zhang F; Song C; Ma Y; Tang L; Xu Y; Wang H
    Int J Mol Med; 2011 Sep; 28(3):365-71. PubMed ID: 21573501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D compounds reduce mammosphere formation and decrease expression of putative stem cell markers in breast cancer.
    Wahler J; So JY; Cheng LC; Maehr H; Uskokovic M; Suh N
    J Steroid Biochem Mol Biol; 2015 Apr; 148():148-55. PubMed ID: 25445919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Hedgehog signalling pathway mediates drug response of MCF-7 mammosphere cells in breast cancer patients.
    He M; Fu Y; Yan Y; Xiao Q; Wu H; Yao W; Zhao H; Zhao L; Jiang Q; Yu Z; Jin F; Mi X; Wang E; Cui Z; Fu L; Chen J; Wei M
    Clin Sci (Lond); 2015 Nov; 129(9):809-22. PubMed ID: 26201092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction with adipocyte stromal cells induces breast cancer malignancy via S100A7 upregulation in breast cancer microenvironment.
    Sakurai M; Miki Y; Takagi K; Suzuki T; Ishida T; Ohuchi N; Sasano H
    Breast Cancer Res; 2017 Jun; 19(1):70. PubMed ID: 28629450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-221 promotes stemness of breast cancer cells by targeting DNMT3b.
    Roscigno G; Quintavalle C; Donnarumma E; Puoti I; Diaz-Lagares A; Iaboni M; Fiore D; Russo V; Todaro M; Romano G; Thomas R; Cortino G; Gaggianesi M; Esteller M; Croce CM; Condorelli G
    Oncotarget; 2016 Jan; 7(1):580-92. PubMed ID: 26556862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of adiponectin and leptin in breast cancer: clinical and in vitro studies.
    Jardé T; Caldefie-Chézet F; Goncalves-Mendes N; Mishellany F; Buechler C; Penault-Llorca F; Vasson MP
    Endocr Relat Cancer; 2009 Dec; 16(4):1197-210. PubMed ID: 19661131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting highly expressed extracellular HSP90 in breast cancer stem cells inhibits tumor growth in vitro and in vivo.
    Stivarou T; Stellas D; Vartzi G; Thomaidou D; Patsavoudi E
    Cancer Biol Ther; 2016 Aug; 17(8):799-812. PubMed ID: 27259689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of the inflammatory profile of stromal cells in human breast cancer: prominent roles for TNF-α and the NF-κB pathway.
    Katanov C; Lerrer S; Liubomirski Y; Leider-Trejo L; Meshel T; Bar J; Feniger-Barish R; Kamer I; Soria-Artzi G; Kahani H; Banerjee D; Ben-Baruch A
    Stem Cell Res Ther; 2015 May; 6(1):87. PubMed ID: 25928089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer stromal fibroblasts promote the generation of CD44+CD24- cells through SDF-1/CXCR4 interaction.
    Huang M; Li Y; Zhang H; Nan F
    J Exp Clin Cancer Res; 2010 Jun; 29(1):80. PubMed ID: 20569497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomics using mammospheres as a model system to identify proteins deregulated in breast cancer stem cells.
    Li G; Zhao F; Cui Y
    Curr Mol Med; 2013 Mar; 13(3):459-63. PubMed ID: 23331018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Propofol Reduced Mammosphere Formation of Breast Cancer Stem Cells via PD-L1/Nanog
    Zhang X; Li F; Zheng Y; Wang X; Wang K; Yu Y; Zhao H
    Oxid Med Cell Longev; 2019; 2019():9078209. PubMed ID: 30906504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leptin attenuates the anti-estrogen effect of tamoxifen in breast cancer.
    Chen X; Zha X; Chen W; Zhu T; Qiu J; Røe OD; Li J; Wang Z; Yin Y
    Biomed Pharmacother; 2013 Feb; 67(1):22-30. PubMed ID: 23199901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leptin/HER2 crosstalk in breast cancer: in vitro study and preliminary in vivo analysis.
    Fiorio E; Mercanti A; Terrasi M; Micciolo R; Remo A; Auriemma A; Molino A; Parolin V; Di Stefano B; Bonetti F; Giordano A; Cetto GL; Surmacz E
    BMC Cancer; 2008 Oct; 8():305. PubMed ID: 18945363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA expression analysis of mammospheres cultured from human breast cancers.
    Feifei N; Mingzhi Z; Yanyun Z; Huanle Z; Fang R; Mingzhu H; Mingzhi C; Yafei S; Fengchun Z
    J Cancer Res Clin Oncol; 2012 Nov; 138(11):1937-44. PubMed ID: 22752669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormonal Therapy Resistance and Breast Cancer: Involvement of Adipocytes and Leptin.
    Delort L; Bougaret L; Cholet J; Vermerie M; Billard H; Decombat C; Bourgne C; Berger M; Dumontet C; Caldefie-Chezet F
    Nutrients; 2019 Nov; 11(12):. PubMed ID: 31756890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Influence factors on the formation of mammospheres from breast cancer stem cells].
    Huang MZ; Zhang FC; Zhang YY
    Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Oct; 40(5):500-4. PubMed ID: 18931713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lentivirus-mediated RNA interference targeting the ObR gene in human breast cancer MCF-7 cells in a nude mouse xenograft model.
    Xue RQ; Gu JC; DU ST; Yu W; Wang Y; Zhang ZT; Bai ZG; Ma XM
    Chin Med J (Engl); 2012 May; 125(9):1563-70. PubMed ID: 22800822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting CXCR1/2 significantly reduces breast cancer stem cell activity and increases the efficacy of inhibiting HER2 via HER2-dependent and -independent mechanisms.
    Singh JK; Farnie G; Bundred NJ; Simões BM; Shergill A; Landberg G; Howell SJ; Clarke RB
    Clin Cancer Res; 2013 Feb; 19(3):643-56. PubMed ID: 23149820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.